China Universal Asset Management Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Buy |
38,890
+250
| +0.6% | +$13.7K | 0.2% | 102 |
|
|
2025
Q1 | $2.73M | Sell |
38,640
-2,144
| -5% | -$152K | 0.25% | 87 |
|
|
2024
Q4 | $2.68M | Buy |
40,784
+3,793
| +10% | +$249K | 0.25% | 86 |
|
|
2024
Q3 | $2.6M | Buy |
36,991
+14,310
| +63% | +$1.01M | 0.29% | 74 |
|
|
2024
Q2 | $1.87M | Sell |
22,681
-13,940
| -38% | -$1.15M | 0.26% | 72 |
|
|
2024
Q1 | $3.2M | Buy |
36,621
+14,465
| +65% | +$1.26M | 0.41% | 55 |
|
|
2023
Q4 | $2.14M | Buy |
22,156
+13,270
| +149% | +$1.28M | 0.42% | 65 |
|
|
2023
Q3 | $786K | Buy |
8,886
+2,372
| +36% | +$210K | 0.23% | 89 |
|
|
2023
Q2 | $565K | Sell |
6,514
-66
| -1% | -$5.72K | 0.17% | 105 |
|
|
2023
Q1 | $640K | Sell |
6,580
-19,350
| -75% | -$1.88M | 0.22% | 86 |
|
|
2022
Q4 | $2.68M | Sell |
25,930
-3,938
| -13% | -$408K | 1.08% | 32 |
|
|
2022
Q3 | $2.53M | Buy |
29,868
+1,737
| +6% | +$147K | 1.07% | 36 |
|
|
2022
Q2 | $2.33M | Buy |
28,131
+21,271
| +310% | +$1.76M | 0.98% | 43 |
|
|
2022
Q1 | $529K | Buy |
+6,860
| New | +$529K | 0.19% | 62 |
|